European Cancer Organisation
login

Interviews

The 2011 Forum, which took place within the groundbreaking European Multidisciplinary Cancer Congress, the largest of its kind in Europe, aimed to bridge the gap between science and policy and covered a wide range of issues related to ‘Health Inequalities’. Discussion on comprehensive strategies to health inequalities were wide-ranging and included action-oriented solutions to improving access to drugs, innovative cancer research, the provision of quality cancer care and evaluating National Cancer Plans. 

 Roundtable brought to you by ecancer.tv.  
video platform video management video solutions video player Prof Michael Baumann (ECCO President)

Prof Michael Baumann explains the principal of multidisciplinarity and its place both in research and clinical practice. Both multidisciplinarity and personalised medicine were at the heart of this year’s Congress and there is now a paradigm shift in cancer therapeutics to ‘fit’ treatment approaches to individual patients.

Prof Baumann explains the concept of the Oncopolicy Forum, which brings scientists together with policymakers, patients and the taxpayer to discuss evidence-based solutions for improved cancer research and care.

Roundtable brought to you by ecancer.tv.
video platform video management video solutions video player

Prof. José Mariano Gago, former Portuguese Minister for Science, Technology and Higher Education

Prof. José Mariano Gago, former Portuguese Minister for Science, Technology and Higher Education, on the role of the biomedical community in science policy, the implications of personalised medicine in the biomedical field,

and on access and use of personal data.

Strategically positioned to move science policy in Europe, Gago argues that the main challenge the scientific community will face is personalising the relation between the outcomes of research and individuals.

Roundtable brought to you by ecancer.tv.

video platform video management video solutions video player

Roger Wilson (Honorary President, Sarcoma UK)

Soft tissue sarcoma survivor Roger Wilson describes the remarkable progress that has been made by the patient organisation he founded in 2003, Sarcoma UK. Not only does this fantastic charity offer advice to patients of this rare form of cancer but it also pools expertise from the clinical and scientific

community and funds laboratory,translational and clinical studies. Roger elaborates on the numerous difficulties facing patients with rare forms of cancer to access clinical trials. A life-saver for many rare cancer patients, the smaller number of patients and the regulatory challenges in conducting

investigator-led multinational clinical trials is a situation sarcoma patients’ face across Europe.

Moreover, poor commercial interest and thus the lack of drug development for rare cancer patients is another significant inequality.

 

 

 

 

 

PRINT THIS PAGE Page last modified: